These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 15073770

  • 21. The effect of intestinal permeability on pancreatic enzyme-induced enteropathy in the rat.
    Lloyd-Still JD, Uhing MR, Arango V, Fusaro A, Kimura RE.
    J Pediatr Gastroenterol Nutr; 1998 May; 26(5):489-95. PubMed ID: 9586757
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. An enteric-coated high-buffered pancrelipase reduces steatorrhea in patients with cystic fibrosis: a prospective, randomized study.
    Brady MS, Garson JL, Krug SK, Kaul A, Rickard KA, Caffrey HH, Fineberg N, Balistreri WF, Stevens JC.
    J Am Diet Assoc; 2006 Aug; 106(8):1181-6. PubMed ID: 16863712
    [Abstract] [Full Text] [Related]

  • 27. Pancreas and cystic fibrosis: the implications of increased survival in cystic fibrosis.
    Krysa J, Steger A.
    Pancreatology; 2007 Aug; 7(5-6):447-50. PubMed ID: 17912009
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Fibrosing colonopathy unrelated to pancreatic enzyme supplementation.
    Taylor CJ.
    J Pediatr Gastroenterol Nutr; 2002 Sep; 35(3):268-9. PubMed ID: 12352511
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Liver disease as risk factor for cystic fibrosis-related diabetes development.
    Minicucci L, Lorini R, Giannattasio A, Colombo C, Iapichino L, Reali MF, Padoan R, Calevo MG, Casciaro R, De Alessandri A, Haupt R.
    Acta Paediatr; 2007 May; 96(5):736-9. PubMed ID: 17381470
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Infant care patterns at epidemiologic study of cystic fibrosis sites that achieve superior childhood lung function.
    Padman R, McColley SA, Miller DP, Konstan MW, Morgan WJ, Schechter MS, Ren CL, Wagener JS, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.
    Pediatrics; 2007 Mar; 119(3):e531-7. PubMed ID: 17332172
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Enteric-coated pancreatic enzyme with bicarbonate is equal to standard enteric-coated enzyme in treating malabsorption in cystic fibrosis.
    Kalnins D, Ellis L, Corey M, Pencharz PB, Stewart C, Tullis E, Durie PR.
    J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):256-61. PubMed ID: 16540792
    [Abstract] [Full Text] [Related]

  • 39. Successful non-invasive treatment of stricturing fibrosing colonopathy in an adult patient.
    Terheggen G, Dieninghoff D, Rietschel E, Drebber U, Kruis W, Leifeld L.
    Eur J Med Res; 2011 Sep 12; 16(9):411-4. PubMed ID: 22024442
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.